Arcturus Therapeutics Holdings Inc (ARCT)
26.99
-0.94
(-3.37%)
USD |
NASDAQ |
Apr 24, 16:00
26.98
-0.01
(-0.04%)
After-Hours: 17:53
Arcturus Therapeutics Holdings Cash from Investing (TTM): -2.901M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -2.901M |
September 30, 2023 | -5.833M |
June 30, 2023 | -7.038M |
March 31, 2023 | -6.306M |
December 31, 2022 | -7.726M |
September 30, 2022 | -5.037M |
June 30, 2022 | -4.617M |
March 31, 2022 | -5.399M |
December 31, 2021 | -3.406M |
September 30, 2021 | -2.985M |
June 30, 2021 | -1.653M |
March 31, 2021 | -1.718M |
December 31, 2020 | -1.742M |
September 30, 2020 | -1.36M |
June 30, 2020 | -1.085M |
March 31, 2020 | -0.882M |
December 31, 2019 | -0.818M |
September 30, 2019 | 1.766M |
June 30, 2019 | 9.748M |
March 31, 2019 | 10.83M |
December 31, 2018 | 22.13M |
Date | Value |
---|---|
September 30, 2018 | 30.32M |
June 30, 2018 | 22.41M |
March 31, 2018 | 14.25M |
December 31, 2017 | 10.36M |
September 30, 2017 | -3.717M |
June 30, 2017 | -7.676M |
March 31, 2017 | 5.386M |
December 31, 2016 | -0.688M |
September 30, 2016 | 8.962M |
June 30, 2016 | 19.79M |
March 31, 2016 | 19.05M |
December 31, 2015 | -0.22M |
September 30, 2015 | 0.95M |
June 30, 2015 | -0.542M |
March 31, 2015 | -3.53M |
December 31, 2014 | 8.407M |
September 30, 2014 | -11.78M |
June 30, 2014 | -28.13M |
March 31, 2014 | -34.12M |
December 31, 2013 | -28.05M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-7.726M
Minimum
Dec 2022
9.748M
Maximum
Jun 2019
-2.578M
Average
-2.901M
Median
Dec 2023
Cash from Investing (TTM) Benchmarks
AIM ImmunoTech Inc | -0.832M |
Perspective Therapeutics Inc | 24.37M |
Protalix BioTherapeutics Inc | -16.71M |
Electromed Inc | -1.219M |
Armata Pharmaceuticals Inc | -8.134M |